Prognosis factors of survival time in patients with glioblastoma multiforme: A multivariate analysis of 340 patients

Acta Neurochirurgica

Volumn 149, Issue 3, 2007, Pages 245-252

  Mineo, J F ^a   Bordron, A ^b   Baroncini, M ^a   Ramirez, C ^a   Maurage, C A ^c   Blond, S ^a   Dam Hieu, P ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CHU MORVAN   (France)

^c University Medical Centre   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Glioblastoma multiforme (GBM); Prognosis; Radiotherapy; Secondary glioblastoma; Surgery; Temozolomide (TMZ)

Indexed keywords

CARMUSTINE; FOTEMUSTINE; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DACARBAZINE; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 33847669866     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-006-1092-y     Document Type: Article

References (30)

1. FK Albert M Forsting K Sartor HP Adams S Kunse 1994 Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis Neurosurgery 34 1 45 61
2. M Bussiere W Hopman A Day AP Pombo T Neves F Espinosa 2005 Indicators of functional status for primary malignant brain tumor patients Can J Neurol Sci 32 1 50 56
3. DR Cox 1972 Regression models and life tables J R Stat Soc B 34 187 220
4. C Daumas-Duport B Scheithauer J O'Fallon P Kelly 1988 Grading of astrocytomas. A simple and reproducible method Cancer 62 10 2152 2165
5. BC Devaux JR O'Fallon PJ Kelly 1993 Resection, biopsy and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome J Neurosurg 78 5 767 775
6. H Fujisawa RM Reis M Nakamura S Colella Y Yonekawa P Kleihues H Ohgaki 2000 Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas Lab Invest 80 1 65 71
7. ME Hegi AC Diserens T Gorlia MF Hamou N De Tribolet M Weller JM Kros JA Hainfeller W Mason L Mariani JE Bromberg P Hau RO Mirimanoff JG Cairncross RC Janser R Stupp 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 10 997 1003
8. EM Hiesiger RL Hayes DM Pierz GN Budzilovich 1993 Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas J Neurooncol 16 2 93 104
9. EL Kaplan P Meier 1958 Non parametric estimation from incomplete observations J Am Stat Assoc 53 457 481
10. GE Keles B Anderson MS Berger 1999 The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere Surg Neurol 52 4 371 379
11. P Kleihues WK Cavenee 2000 Pathology and genetic of tumors of the nervous system: World Health Organization Classification of tumors 1 IARC Press Lyon, France 55 69
12. P Kleihues H Ohgaki 1999 Primary and secondary glioblastomas: from concept to clinical diagnosis Neuro-Oncology 1 44 51
13. M Lacroix D Abi-Said DR Fourney ZL Gokaslan W Shi F Demonte FF Lang IE [tmp] McCutcheon SJ Hassenbusch E Holland K Hess C Michael D Miller R Sawaya 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extend of resection of resection and survival J Neurosurg 95 2 190 198
14. FF Lang DC Miller M Koslow EW Newcomb 1994 Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors J Neurosurg 81 3 427 436
15. A Mangiola G Maira P De Bonis P Porso B Pettorini G Sabatino C Anile 2006 Glioblastoma multiforme in the elderly: a therapeutic challenge J Neurooncol 76 2 159 163
16. JF Mineo I Quintin-Roue B Lucas V Buburuzan G Besson 2002 Glioblastomas: clinical study and prognosis factors Neurochirurgie 48 6 500 509
17. ®) induces cellular death of glioblastomas Br J Cancer 91 6 1195 1199
18. M Nozaki M Tada H Kobayashi CL Zhang Y Sawamura H Abe N Ishii EG Van Meir 1999 Roles of the functional loss of P53 and other genes in astrocytoma tumorigenesis and progression Neuro-Oncology 1 2 124 137
19. A Obwegeser M Ortler M Seiwald H Ulmer H Kostron 1995 Therapy of glioblastoma multiforme: a cumulative experience of 10 years Acta Neurochir (Wien) 137 1 29 33
20. H Ohgaki P Kleihues 2005 Epidemiology and etiology of gliomas Acta Neuropathol 109 1 93 108
21. RS Polin NF Marko MD Ammerman ME Shaffrey W Huang FA Anderson Jr AJ Caputy ER Laws 2005 Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres J Neurosurg 102 2 276 283
22. F Puzzilli A Ruggeri L Mastronardi D Di Stephano P Lunardi 1998 Long-term survival in cerebral glioblastoma. Case report and critical review of the literature Tumori 84 1 69 74
23. NG Rainov KU Dobberstein H Bahn HJ Holzhausen C Lautenschlager V Heideke W Burkert 1997 Prognosis factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival J Neurooncol 35 1 13 28
24. J Shinoda N Sakai S Murase H Yano T Matsuhisa T Funakoshi 2001 Selection of eligible patients with supratentorial glioblastoma gross total resection J Neurooncol 52 2 161 171
25. DC Shrieve E Alexander PM Black PY Wen HA Fine HM Kooy JS Loeffler 1999 Treatment of patient with primary glioblastoma multiforme with standart postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome J Neurosurg 90 1 72 77
26. DL Silbergeld RC Rostomily EC Alvord Jr 1991 The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults J Neurooncol 10 2 179 185
27. AM Stark A Nabavi HM Mehdorn U Blömer 2005 Glioblastoma multiforme: report of 267 cases treated at a single institution Surg Neurol 63 2 162 169
28. W Stummer A Novotny H Stepp C Goetz K Bize HJ Reulen 2000 Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid induced porphyrins: a prospective study of 52 consecutive patients J Neurosurg 93 6 1003 1013
29. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curshmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 996
30. Y Tohma C Gratas W Biernat A Peraud M Fukuda Y Yonekawa P Kleihues H Ohgaki 1998 PTEN (MMAC1) Mutation are frequent in primary glioblastomas but not in secondary glioblastomas J Neuropathol Exp Neurol 57 7 684 689